Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marieke Willemsen

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Biotechnology and Bioengineering|October 24, 2008
Modeling Neisseria meningitidis B metabolism at different specific growth ratesGino J E Baart, Marieke Willemsen, Elnaz Khatami, et al.
Vaccine|March 19, 2024
High throughput AS LNA qPCR method for the detection of a specific mutation in poliovirus vaccine strainsLizet Opmeer, Isabella Gazzoli, Mónika Ballmann, et al.
Vaccine|March 4, 2025
Sabin inactivated polio vaccine upstream process development using fixed-bed bioreactor technologyAhd Hamidi, Marieke Willemsen, Thomas Robert, et al.
Vaccine|August 26, 2011
Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trialRebecca J Cox, Gabriel Pedersen, Abdullah S Madhun, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Biotechnology and Bioengineering|October 24, 2008
Modeling Neisseria meningitidis B metabolism at different specific growth ratesGino J E Baart, Marieke Willemsen, Elnaz Khatami, et al.
Vaccine|March 19, 2024
High throughput AS LNA qPCR method for the detection of a specific mutation in poliovirus vaccine strainsLizet Opmeer, Isabella Gazzoli, Mónika Ballmann, et al.
Vaccine|March 4, 2025
Sabin inactivated polio vaccine upstream process development using fixed-bed bioreactor technologyAhd Hamidi, Marieke Willemsen, Thomas Robert, et al.
Vaccine|August 26, 2011
Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trialRebecca J Cox, Gabriel Pedersen, Abdullah S Madhun, et al.
Pageof 1